Immune design corp. (IMDZ)
CashFlow / Quarterly
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-13,601

-14,049

-13,808

-13,300

-11,980

-13,416

-13,846

-12,620

-14,446

-12,443

-14,347

-12,294

-12,115

-7,407

-10,517

-9,406

-13,120

-6,682

-6,126

-8,223

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

78

82

102

84

95

87

90

79

76

77

75

76

66

66

59

52

61

55

61

61

Amortization of premium/discount on investments

130

139

142

150

71

11

-30

-26

-156

2

-20

48

0

0

0

0

-

-

-

-

Stock-based compensation

1,224

1,803

1,511

2,738

2,032

2,149

2,205

2,247

2,376

2,326

2,246

2,335

1,846

1,407

1,813

1,231

466

424

267

187

Revaluation of convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

127

1,439

2,711

Changes in operating assets and liabilities:
Accounts receivable

-75

120

320

-307

127

25

-108

86

-6,977

7,117

364

-959

-2,171

2,264

-699

-392

1,920

-988

1,026

-75

Inventory

-18

454

226

-10

76

-16

48

-31

-102

-15

19

692

-294

-127

407

2

-456

462

5

-3

Prepaid expenses

-

617

-403

943

-

1,114

-588

-635

-

1,018

640

1,240

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-349

148

-155

-181

645

145

Other assets

1,543

155

-9

-3,037

21

2,990

-23

-3,010

3,059

0

0

0

-

-

-

-

-

-

-

-

Accounts payable

-1,341

-337

526

296

-218

-1,694

932

-1,245

208

823

1,763

-1,309

395

663

-407

-4,480

3,833

1,815

318

71

Accrued liabilities

1,603

1,019

1,024

-2,465

557

-140

1,558

-772

239

-2,405

2,973

169

38

313

1,701

-2,571

1,661

1,676

-34

121

Accrued litigation-related settlement

0

0

0

-6,000

-1,250

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other noncurrent liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

-9

523

-7

-7

-2

Deferred rent and other liabilities

-

1

2

3

-

-16

25

-2,486

-

2,972

-4

-96

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-12,966

-10,919

-16,383

-

-17,179

-8,660

-11,181

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-12,140

-7,543

-8,600

-6,717

-14,941

-7,885

-1,885

-5,758

-5,141

Investing activities
Purchases of property and equipment

121

26

39

204

84

83

59

202

57

22

35

19

119

102

74

132

153

74

58

59

Maturities of short-term investments

27,000

17,000

21,000

21,000

15,000

22,000

19,000

9,000

17,000

17,000

6,000

0

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

8,903

8,915

10,921

-

11,966

2,999

8,999

-

17,000

2,000

46,000

0

0

0

0

-

-

-

-

Net cash provided by investing activities

-

8,071

12,046

9,875

-

9,951

15,942

-201

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-46,019

-119

-102

-74

-132

-153

-74

-58

-59

Financing activities
Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

-

-

1,197

171

Proceeds from issuances of common stock under stock-based compensation plans

-129

0

131

226

31

286

111

286

18

25

101

0

93

194

72

77

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

0

93

194

75,559

-51

4

67,344

-1,197

-171

Net cash provided by financing activities

-

0

131

226

-

286

111

286

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents

9,406

-4,895

1,258

-6,282

44,085

-6,942

7,393

-11,096

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow information
Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

19,903

-4,231

-58,159

-7,569

-8,508

68,768

-15,124

-8,034

65,385

-7,013

-5,371

Stock offering costs incurred, not yet paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

-

-

230

167